Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MLAB 
Mesa Laboratories Inc (MLAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: MLAB (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $121.67
1 Year Target Price $121.67
| 2 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -51.1% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 514.01M USD | Price to earnings Ratio - | 1Y Target Price 121.67 |
Price to earnings Ratio - | 1Y Target Price 121.67 | ||
Volume (30-day avg) 4 | Beta 0.89 | 52 Weeks Range 85.59 - 154.70 | Updated Date 07/1/2025 |
52 Weeks Range 85.59 - 154.70 | Updated Date 07/1/2025 | ||
Dividends yield (FY) 0.65% | Basic EPS (TTM) -0.36 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.82% | Operating Margin (TTM) 2.36% |
Management Effectiveness
Return on Assets (TTM) 2.5% | Return on Equity (TTM) -1.29% |
Valuation
Trailing PE - | Forward PE 35.21 | Enterprise Value 668926035 | Price to Sales(TTM) 2.13 |
Enterprise Value 668926035 | Price to Sales(TTM) 2.13 | ||
Enterprise Value to Revenue 2.78 | Enterprise Value to EBITDA 15.8 | Shares Outstanding 5455440 | Shares Floating 5298430 |
Shares Outstanding 5455440 | Shares Floating 5298430 | ||
Percent Insiders 5.98 | Percent Institutions 96.44 |
Analyst Ratings
Rating 2 | Target Price 121.67 | Buy - | Strong Buy 2 |
Buy - | Strong Buy 2 | ||
Hold 1 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Mesa Laboratories Inc
Company Overview
History and Background
Mesa Laboratories, Inc. was founded in 1982. It provides instruments and services for quality control in regulated industries, with a focus on sterilization and other contamination control processes. The company has grown through organic development and acquisitions.
Core Business Areas
- Sterilization and Disinfection Control: Provides sterilization indicators, equipment, and services to healthcare, pharmaceutical, and medical device industries. Includes biological indicators (BIs), chemical indicators (CIs), and monitoring systems.
- Continuous Monitoring: Offers real-time monitoring systems for environmental parameters (temperature, pressure, humidity) in pharmaceutical and industrial applications.
- Data Loggers: Designs and manufactures data loggers used to monitor temperature, humidity, and pressure in various applications, including pharmaceutical, food, and transportation.
- Biopharmaceutical Development: Provides contract services for biopharmaceutical development, including assay development, cell line development, and biosafety testing.
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives. The organizational structure is based on business segments, with each segment having its own management team and reporting structure.
Top Products and Market Share
Key Offerings
- Biological Indicators (BIs): Used to monitor the effectiveness of sterilization processes. Mesa Labs is a major player in the BI market. Competitors include STERIS, 3M, and Cantel Medical (now part of STERIS). Market share information is difficult to obtain precisely, but Mesa Labs is estimated to be a leading provider.
- Market Share: Estimated to be in the top 3 providers worldwide.
- DataTrace Data Loggers: Wireless, high-temperature data loggers used in pharmaceutical and food processing. Competitors include Vaisala and Dickson.
- Market Share: Estimated to be in the top 3 providers worldwide.
- Apex PRO Sterilization Verification System: An automated system for verifying the effectiveness of sterilization. Competitors include 3M, STERIS
- Market Share: Estimated to be in the top 3 providers worldwide.
Market Dynamics
Industry Overview
The sterilization and contamination control market is driven by stringent regulations in healthcare, pharmaceutical, and food industries. The market is growing due to increasing awareness of infection control and the need for reliable monitoring systems.
Positioning
Mesa Labs is a leading provider of sterilization and contamination control solutions. Its competitive advantages include its reputation for quality, its wide range of products, and its strong customer relationships.
Total Addressable Market (TAM)
The total addressable market for sterilization and contamination control is estimated to be several billion USD. Mesa Labs is positioned to capture a significant share of this market with its diverse product portfolio and strong customer base.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Wide range of products and services
- Established customer base
- High-quality products
- Experienced management team
Weaknesses
- Limited geographic presence compared to larger competitors
- Dependence on regulatory compliance
- Smaller scale compared to larger competitors
- Potential impact from economic downturns
Opportunities
- Expanding into new geographic markets
- Developing new products and services
- Acquiring complementary businesses
- Increasing demand for sterilization and contamination control solutions
Threats
- Intense competition
- Changing regulations
- Economic downturn
- Product liability claims
Competitors and Market Share
Key Competitors
- STERIS (STE)
- 3M (MMM)
- Cantel Medical (Now part of STERIS)
Competitive Landscape
Mesa Labs competes with larger companies like STERIS and 3M, but it has a strong reputation for quality and a loyal customer base. Mesa Labs advantages include its specialized focus and expertise in sterilization and contamination control. A disadvantage is its smaller scale compared to major competitors.
Major Acquisitions
Agena Bioscience, Inc.
- Year: 2021
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expand diagnostic offerings and market reach in molecular testing.
Growth Trajectory and Initiatives
Historical Growth: Mesa Labs has historically grown through organic development and strategic acquisitions.
Future Projections: Future growth projections depend on market conditions, regulatory changes, and company strategy which require access to real-time consensus estimates.
Recent Initiatives: Recent initiatives include acquisitions to expand product offerings and market presence. Specific details are unavailable without real-time access.
Summary
Mesa Labs is a reputable company within the sterilization and contamination control industry. Its strengths include a diverse product portfolio and acquisitions strategy. The company should closely monitor regulatory changes and competitive pressures. Future growth will depend on successful integration of acquisitions and expanding into new markets.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Industry reports
- Market research reports
Disclaimers:
This analysis is based on publicly available information and estimates. Actual results may vary. The market share data is approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mesa Laboratories Inc
Exchange NASDAQ | Headquaters Lakewood, CO, United States | ||
IPO Launch date 1995-01-25 | CEO, President & Director Mr. Gary M. Owens | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 730 | Website https://www.mesalabs.com |
Full time employees 730 | Website https://www.mesalabs.com | ||
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.